Management of Diarrhea After Ileostomy Reversal
Loperamide is the first-line treatment for diarrhea following ileostomy reversal, with doses of 4 mg taken four times daily or higher (12-24 mg at a time) often required due to disrupted enterohepatic circulation. 1, 2
Initial Assessment and Common Causes
After ileostomy reversal, diarrhea is common and requires systematic evaluation to identify the underlying cause:
- Bile acid malabsorption occurs in more than 80% of patients following ileal resection and is a primary cause of post-reversal diarrhea 1
- Small intestinal bacterial overgrowth affects approximately 30% of patients after intestinal resection, particularly with blind loops, dysmotility, or strictures 1
- Recurrent Crohn's disease should be evaluated if inflammatory bowel disease was the original indication 1
- Structural complications including anastomotic strictures, adhesions, or obstruction must be excluded 1
Pharmacologic Management Algorithm
First-Line: Antimotility Agents
Loperamide is preferred over codeine phosphate because it is non-sedative, non-addictive, and does not cause fat malabsorption 1:
- Start with 4 mg four times daily (taken 30 minutes before meals to maximize effect) 1, 3
- If inadequate response, increase to 12-24 mg per dose due to rapid small bowel transit and disrupted enterohepatic circulation in post-surgical patients 1
- Loperamide reduces water and sodium output by approximately 20-30% 1
- FDA-approved specifically for reducing discharge volume from ileostomies 2
If tablets emerge unchanged in stool, crush them or mix with water before administration 1
Second-Line: Bile Acid Sequestrants
For patients with suspected bile acid malabsorption (the majority after ileal resection), initiate a therapeutic trial of bile acid sequestrants 1:
- Colestyramine is first-line but may be unpalatable 1
- Colesevelam is better tolerated as an alternative 1
- A therapeutic trial is more practical than SeHCAT scanning, which is often abnormal post-resection regardless of whether symptoms are bile acid-related 1
Third-Line: Antisecretory Agents
For persistent high-volume diarrhea (>2 liters daily), add gastric acid suppression 1:
- Omeprazole 40 mg once daily orally, or twice daily intravenously if less than 50 cm of jejunum remains 1
- Ranitidine 300 mg twice daily as alternative 1
- These agents reduce jejunal output particularly in patients with net secretory losses 1
Fourth-Line: Octreotide
Reserve octreotide for refractory cases with problematic fluid and electrolyte management despite conventional treatments 1:
- Dose: 50 mcg subcutaneously twice daily 1
- Monitor carefully for fluid retention upon initiation 1
- May interfere with intestinal adaptation during long-term use 1
- Requires objective measurement of effects with adjustment of parenteral support accordingly 1
Dietary and Fluid Management
Dietary modifications are essential adjuncts to pharmacologic therapy 3:
- Bulking agents: Marshmallows, bananas, pasta, rice, white bread, mashed potatoes help thicken output 1, 3
- Fluid intake: Maintain 2-2.5 liters daily to prevent dehydration 3
- Avoid hypotonic fluids (tea, water) and hypertonic drinks (fruit juice) which increase output 3
- Increase sodium intake: Add 0.5-1 teaspoon extra salt daily to meals 3
- Limit high fiber foods initially as they increase loose stools and bloating 3
Antibiotic Therapy for Bacterial Overgrowth
For patients with suspected small intestinal bacterial overgrowth (bloating, nausea, weight loss), empirical treatment with rifaximin is recommended 1:
- Breath testing has poor sensitivity/specificity; empirical treatment is preferred when clinically suspected 1
- Recurrent courses may be required 1
Monitoring and Red Flags
If diarrhea persists despite these interventions, investigate for 1:
- Anastomotic complications or strictures (consider endoscopy at 6 months if Crohn's disease) 1
- C. difficile infection 1
- Recurrent inflammatory disease (check fecal calprotectin) 1
- Functional bowel disorders 1
Critical Pitfalls to Avoid
- Do not use standard loperamide doses (2-4 mg) in post-reversal patients; much higher doses are typically required 1
- Do not assume all post-reversal diarrhea is inflammatory; bile acid malabsorption and bacterial overgrowth are more common 1
- Do not order SeHCAT scanning routinely; it will be abnormal after ileal resection regardless, so proceed directly to therapeutic trial 1
- Monitor for dehydration and acute kidney injury, which causes 9.3% of readmissions after ileostomy creation/reversal 4